| Q51022113 | 4–1BB signal stimulates the activation, expansion, and effector functions of γδ T cells in mice and humans |
| Q36410082 | A Photo-Crosslinkable Biotin Derivative of the Phosphoantigen (E)-4-Hydroxy-3-Methylbut-2-Enyl Diphosphate (HMBPP) Activates Vγ9Vδ2 T Cells and Binds to the HMBPP Site of BTN3A1. |
| Q28829233 | A Subset of Protective γ9δ2 T Cells Is Activated by Novel Mycobacterial Glycolipid Components |
| Q40338119 | A key malaria metabolite modulates vector blood seeking, feeding, and susceptibility to infection. |
| Q58543705 | A power law function describes the time- and dose-dependency of Vγ9Vδ2 T cell activation by phosphoantigens |
| Q33410795 | A rapid crosstalk of human gammadelta T cells and monocytes drives the acute inflammation in bacterial infections |
| Q34002174 | A role for the mevalonate pathway in the induction of subtype cross-reactive immunity to influenza A virus by human gammadelta T lymphocytes |
| Q36232232 | ATP release and autocrine signaling through P2X4 receptors regulate γδ T cell activation |
| Q51741445 | Adjuvant Bisphosphonate Therapy in Postmenopausal Breast Cancer. |
| Q27004178 | Adoptive T-cell therapy using autologous tumor-infiltrating lymphocytes for metastatic melanoma: current status and future outlook |
| Q40205361 | Adoptive Transfer of Phosphoantigen-Specific γδ T Cell Subset Attenuates Mycobacterium tuberculosis Infection in Nonhuman Primates. |
| Q90090369 | Alpaca (Vicugna pacos), the first nonprimate species with a phosphoantigen-reactive Vγ9Vδ2 T cell subset |
| Q36759195 | Analysis of Immune Cells from Human Mammary Ductal Epithelial Organoids Reveals Vδ2+ T Cells That Efficiently Target Breast Carcinoma Cells in the Presence of Bisphosphonate |
| Q92438871 | Analysis of macaque BTN3A genes and transcripts in the extended MHC: conserved orthologs of human γδ T cell modulators |
| Q38890709 | Are human iNKT cells keeping tabs on lipidome perturbations triggered by oxidative stress in the blood? |
| Q38151057 | At the Bench: Preclinical rationale for exploiting NK cells and γδ T lymphocytes for the treatment of high-risk leukemias |
| Q40070853 | BTN3A1 Discriminates γδ T Cell Phosphoantigens from Nonantigenic Small Molecules via a Conformational Sensor in Its B30.2 Domain |
| Q51669127 | Blocking of CD1d Decreases Trypanosoma cruzi-Induced Activation of CD4-CD8- T Cells and Modulates the Inflammatory Response in Patients With Chagas Heart Disease |
| Q89259591 | Bohemian T cell receptors: sketching the repertoires of unconventional lymphocytes |
| Q64980540 | Bone-Modifying Agents in Early-Stage and Advanced Breast Cancer. |
| Q35945802 | Bovine Gamma Delta T Cells Contribute to Exacerbated IL-17 Production in Response to Co-Infection with Bovine RSV and Mannheimia haemolytica |
| Q38848635 | Butyrophilin 3A (BTN3A, CD277)-specific antibody 20.1 differentially activates Vγ9Vδ2 TCR clonotypes and interferes with phosphoantigen activation |
| Q27685257 | Butyrophilin 3A1 binds phosphorylated antigens and stimulates human γδ T cells |
| Q28660812 | Butyrophilin 3A1 plays an essential role in prenyl pyrophosphate stimulation of human Vγ2Vδ2 T cells |
| Q90187881 | Butyrophilin-2A1 Directly Binds Germline-Encoded Regions of the Vγ9Vδ2 TCR and Is Essential for Phosphoantigen Sensing |
| Q54268399 | Butyrophilin3A proteins and Vγ9Vδ2 T cell activation. |
| Q50308633 | Butyrophilins: an important new element of resistance |
| Q54209309 | CD3ε Expression Defines Functionally Distinct Subsets of Vδ1 T Cells in Patients With Human Immunodeficiency Virus Infection. |
| Q43749801 | CD4+ CD25(high) Foxp3+ regulatory T cells downregulate human Vdelta2+ T-lymphocyte function triggered by anti-CD3 or phosphoantigen |
| Q42684191 | CD70-CD27 interactions provide survival and proliferative signals that regulate T cell receptor-driven activation of human γδ peripheral blood lymphocytes |
| Q26782520 | CD8⁺ T Cell-Independent Immune-Mediated Mechanisms of Anti-Tumor Activity |
| Q34636212 | CRTAM Receptor Engagement by Necl-2 on Tumor Cells Triggers Cell Death of Activated Vγ9Vδ2 T Cells |
| Q38283536 | Cancer Immunotherapy Using γδT Cells: Dealing with Diversity |
| Q41750241 | Characterisation of gamma delta (γδ) T cell populations in patients with sepsis |
| Q64968682 | Checkpoint Blockade Rescues the Repressive Effect of Histone Deacetylases Inhibitors on γδ T Cell Function. |
| Q37681825 | Clonal selection in the human Vδ1 T cell repertoire indicates γδ TCR-dependent adaptive immune surveillance |
| Q37127038 | Comparison of γδ T cell responses and farnesyl diphosphate synthase inhibition in tumor cells pretreated with zoledronic acid. |
| Q39028978 | Critical role of butyrophilin 3A1 in presenting prenyl pyrophosphate antigens to human γδ T cells |
| Q37114832 | Cross-presenting human gammadelta T cells induce robust CD8+ alphabeta T cell responses |
| Q37039445 | Cutting edge: CD1d restriction and Th1/Th2/Th17 cytokine secretion by human Vδ3 T cells. |
| Q34249937 | Cytokine requirements for the differentiation and expansion of IL-17A- and IL-22-producing human Vgamma2Vdelta2 T cells. |
| Q40207403 | Cytokine-mediated activation of human ex vivo-expanded Vγ9Vδ2 T cells. |
| Q33562231 | Cytomegalovirus-induced gammadelta T cells associate with reduced cancer risk after kidney transplantation |
| Q34263653 | Deep Sequencing of the Human TCRγ and TCRβ Repertoires Suggests that TCRβ Rearranges After αβ and γδ T Cell Commitment |
| Q27026152 | Defining the nature of human γδ T cells: a biographical sketch of the highly empathetic |
| Q84775360 | Design of potent bisphosphonate inhibitors of the human farnesyl pyrophosphate synthase via targeted interactions with the active site ‘capping’ phenyls |
| Q90259222 | Development and Selection of the Human Vγ9Vδ2+ T-Cell Repertoire |
| Q64275919 | Early Pregnancy Human Decidua is Enriched with Activated, Fully Differentiated and Pro-Inflammatory Gamma/Delta T Cells with Diverse TCR Repertoires |
| Q26800118 | Early innate responses to pathogens: pattern recognition by unconventional human T-cells |
| Q24321574 | Ecto-F1-ATPase and MHC-class I close association on cell membranes |
| Q26781175 | Empowering gamma delta T cells with antitumor immunity by dendritic cell-based immunotherapy |
| Q37655345 | Enhancing adoptive cancer immunotherapy with Vγ2Vδ2 T cells through pulse zoledronate stimulation |
| Q44111917 | Essential Requirements of Zoledronate-Induced Cytokine and γδ T Cell Proliferative Responses |
| Q36560292 | Evaluation of a 7-Methoxycoumarin-3-carboxylic Acid Ester Derivative as a Fluorescent, Cell-Cleavable, Phosphonate Protecting Group. |
| Q37534913 | Evasion and subversion of antigen presentation by Mycobacterium tuberculosis |
| Q55008660 | Expansion of Gammadelta T Cells from Cord Blood: A Therapeutical Possibility |
| Q47666620 | Expansion of human γδ T cells for adoptive immunotherapy using a bisphosphonate prodrug |
| Q39602547 | Expression and function of PD-1 in human γδ T cells that recognize phosphoantigens |
| Q35111018 | Flanking V and J Sequences of Complementary Determining Region 3 of T Cell Receptor (TCR) δ1 (CDR3δ1) Determine the Structure and Function of TCRγ4δ1 |
| Q36745233 | Frequent Malaria Drives Progressive Vδ2 T-Cell Loss, Dysfunction, and CD16 Up-regulation During Early Childhood |
| Q36732632 | Frontline T cells: gammadelta T cells and intraepithelial lymphocytes |
| Q34881512 | Gamma delta T cell reconstitution is associated with fewer infections and improved event-free survival after hematopoietic stem cell transplantation for pediatric leukemia. |
| Q38101588 | Gammadelta T cells: innately adaptive immune cells? |
| Q55613890 | Gene expression pattern of TCR repertoire and alteration expression of IL-17A gene of γδ T cells in patients with acute myocardial infarction. |
| Q98735518 | Get in Touch With Dendritic Epithelial T Cells! |
| Q34550753 | Granzyme A produced by γ(9)δ(2) T cells induces human macrophages to inhibit growth of an intracellular pathogen. |
| Q37072016 | HMBPP Analog Prodrugs Bypass Energy-Dependent Uptake To Promote Efficient BTN3A1-Mediated Malignant Cell Lysis by Vγ9Vδ2 T Lymphocyte Effectors |
| Q34484069 | HMBPP-deficient Listeria mutant immunization alters pulmonary/systemic responses, effector functions, and memory polarization of Vγ2Vδ2 T cells |
| Q27027547 | Harnessing the power of Vδ2 cells in cancer immunotherapy |
| Q37515155 | Heterogeneous yet stable Vδ2(+) T-cell profiles define distinct cytotoxic effector potentials in healthy human individuals |
| Q33455830 | Highly active microbial phosphoantigen induces rapid yet sustained MEK/Erk- and PI-3K/Akt-mediated signal transduction in anti-tumor human gammadelta T-cells |
| Q42740131 | How to exploit stress-related immunity against Hodgkin's lymphoma: Targeting ERp5 and ADAM sheddases. |
| Q34025938 | Human Ovarian Tumor Cells Escape γδ T Cell Recognition Partly by Down Regulating Surface Expression of MICA and Limiting Cell Cycle Related Molecules |
| Q59806965 | Human Vγ9Vδ2 T Lymphocytes in the Immune Response to Infection |
| Q64263045 | Human Vδ1 T Cells in the Immune Response to Infection |
| Q41613391 | Human Vδ2(+) γδ T Cells Differentially Induce Maturation, Cytokine Production, and Alloreactive T Cell Stimulation by Dendritic Cells and B Cells. |
| Q33795023 | Human cytomegalovirus elicits fetal gammadelta T cell responses in utero |
| Q41812496 | Human gamma delta T lymphocytes for immunotherapeutic strategies against cancer |
| Q26822639 | Human isoprenoid synthase enzymes as therapeutic targets |
| Q33904052 | Human neutrophil clearance of bacterial pathogens triggers anti-microbial γδ T cell responses in early infection |
| Q89794792 | Human unconventional T cells in Plasmodium falciparum infection |
| Q55006062 | Human γδ T-Cell Control of Mucosal Immunity and Inflammation. |
| Q38027044 | Human γδ T-cell responses in infection and immunotherapy: common mechanisms, common mediators? |
| Q90737012 | Human γδ TCR Repertoires in Health and Disease |
| Q64084944 | IL-12 Expands and Differentiates Human Vγ2Vδ2 T Effector Cells Producing Antimicrobial Cytokines and Inhibiting Intracellular Mycobacterial Growth |
| Q39729244 | Identification of a panel of ten cell surface protein antigens associated with immunotargeting of leukemias and lymphomas by peripheral blood gammadelta T cells |
| Q90493893 | Identification of a tumor-specific allo-HLA-restricted γδTCR |
| Q38752243 | Immune-mediated syndromes following intravenous bisphosphonate therapy |
| Q34965681 | Immunogenic and antioxidant effects of a pathogen-associated prenyl pyrophosphate in Anopheles gambiae |
| Q37991783 | Immunomodulatory drugs in multiple myeloma: from molecular mechanisms of action to clinical practice |
| Q90050645 | Improved Overall Survival, Relapse-Free-Survival, and Less Graft-vs.-Host-Disease in Patients With High Immune Reconstitution of TCR Gamma Delta Cells 2 Months After Allogeneic Stem Cell Transplantation |
| Q55311835 | Improving the Efficiency of Vγ9Vδ2 T-Cell Immunotherapy in Cancer |
| Q35889808 | Indirect stimulation of human Vγ2Vδ2 T cells through alterations in isoprenoid metabolism |
| Q84819752 | Inhibition of murine gammadelta lymphocyte expansion and effector function by regulatory alphabeta T cells is cell-contact-dependent and sensitive to GITR modulation |
| Q45715422 | Innate Immune Recognition: Implications for the Interaction of Francisella tularensis with the Host Immune System |
| Q28085321 | Innate-like lymphocytes in intestinal infections |
| Q37737540 | Insights into Local Tumor Microenvironment Immune Factors Associated with Regression of Cutaneous Melanoma Metastases by Mycobacterium bovis Bacille Calmette-Guérin |
| Q39748470 | It May Seem Inflammatory, but Some T Cells Are Innately Healing to the Bone. |
| Q24339540 | Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human γδ T-cell subset |
| Q38013197 | Licensing of killer dendritic cells in mouse and humans: Functional similarities between IKDC and human blood γδ T-lymphocytes |
| Q97692776 | Ligand recognition by the γδ TCR and discrimination between homeostasis and stress conditions |
| Q36835155 | Long-term expansion of effector/memory Vdelta2-gammadelta T cells is a specific blood signature of CMV infection |
| Q36883879 | Mechanisms of the antitumor activity of human Vγ9Vδ2 T cells in combination with zoledronic acid in a preclinical model of neuroblastoma. |
| Q34560345 | Metabolic engineering of Salmonella vaccine bacteria to boost human Vγ2Vδ2 T cell immunity. |
| Q34218508 | Microbe-specific unconventional T cells induce human neutrophil differentiation into antigen cross-presenting cells |
| Q49838268 | Mixed Aryl Phosphonate Prodrugs of a Butyrophilin Ligand |
| Q34819275 | Molecules and Mechanisms Implicated in the Peculiar Antigenic Activation Process of Human Vγ9Vδ2 T Cells |
| Q90514963 | Mucosal-associated invariant T cells and Vδ2+ γδ T cells in community acquired pneumonia: association of abundance in sputum with clinical severity and outcome |
| Q42573316 | Mycobacteria activate γδ T-cell anti-tumour responses via cytokines from type 1 myeloid dendritic cells: a mechanism of action for cancer immunotherapy |
| Q54691443 | Neutrophil uptake of nitrogen-bisphosphonates leads to the suppression of human peripheral blood γδ T cells. |
| Q46967847 | Neutrophils suppress γδ T-cell function |
| Q90233130 | Novel Immunotherapeutic Approaches for Neuroblastoma and Malignant Melanoma |
| Q42923573 | Novel bisphosphonate inhibitors of the human farnesyl pyrophosphate synthase |
| Q87733797 | OMIP-020: phenotypic characterization of human γδ T-cells by multicolor flow cytometry |
| Q35192774 | Obesity impairs γδ T cell homeostasis and antiviral function in humans |
| Q37883493 | Optimizing vaccine development |
| Q37695890 | Ovine skin-recirculating γδ T cells express IFN-γ and IL-17 and exit tissue independently of CCR7 |
| Q34502154 | Pathogen-Specific Immune Fingerprints during Acute Infection: The Diagnostic Potential of Human γδ T-Cells. |
| Q40873552 | Pathophysiology of peritonitis |
| Q37226209 | Phenotypic and functional alterations of Vgamma2Vdelta2 T cell subsets in patients with active nasopharyngeal carcinoma. |
| Q34970077 | Phosphoantigen Presentation to TCR γδ Cells, a Conundrum Getting Less Gray Zones |
| Q40093467 | Phosphoantigen-induced conformational change of butyrophilin 3A1 (BTN3A1) and its implication on Vγ9Vδ2 T cell activation |
| Q47165356 | Phosphonic acid: preparation and applications |
| Q27653670 | Phosphorylated self-peptides alter human leukocyte antigen class I-restricted antigen presentation and generate tumor-specific epitopes |
| Q37226687 | Photoaffinity antigens for human gammadelta T cells |
| Q38265506 | Potential Use of γδ T Cell-Based Vaccines in Cancer Immunotherapy. |
| Q48104723 | Prediction of Disordered Regions and Their Roles in the Anti-Pathogenic and Immunomodulatory Functions of Butyrophilins. |
| Q34595188 | Preferential Th1 cytokine profile of phosphoantigen-stimulated human Vγ9Vδ2 T cells. |
| Q34967135 | Probenecid as a sensitizer of bisphosphonate-mediated effects in breast cancer cells |
| Q33928383 | Prolonged antigen survival and cytosolic export in cross-presenting human gammadelta T cells |
| Q28049695 | Protection against malaria at 1 year and immune correlates following PfSPZ vaccination |
| Q115902706 | RETRACTED ARTICLE: A two-pronged attack on antibiotic-resistant microbes |
| Q37362470 | Response of gammadelta T Cells to plant-derived tannins. |
| Q90521943 | Revisiting the Interaction of γδ T-Cells and B-Cells |
| Q37279963 | RhoB Mediates Phosphoantigen Recognition by Vγ9Vδ2 T Cell Receptor |
| Q37871903 | Searching for "signal 2": costimulation requirements of γδ T cells. |
| Q45866963 | Sensing Bad: Are Co-stimulatory CAR-Expressing γδ T Cells Safer? |
| Q36845046 | Sensor Function for Butyrophilin 3A1 in Prenyl Pyrophosphate Stimulation of Human Vγ2Vδ2 T Cells |
| Q27010451 | Six-of-the-best: unique contributions of γδ T cells to immunology |
| Q39807695 | Specific requirements for Vgamma9Vdelta2 T cell stimulation by a natural adenylated phosphoantigen. |
| Q92937452 | Stability and Efficiency of Mixed Aryl Phosphonate Prodrugs |
| Q37692269 | Staphylococcus aureus infection of mice expands a population of memory γδ T cells that are protective against subsequent infection. |
| Q37079078 | Stereotaxic administrations of allogeneic human Vγ9Vδ2 T cells efficiently control the development of human glioblastoma brain tumors. |
| Q40953833 | Stress-related and homeostatic cytokines regulate Vγ9Vδ2 T-cell surveillance of mevalonate metabolism. |
| Q95847211 | Structure-Activity Relationships of Butyrophilin 3 Ligands |
| Q45792189 | Suppression of pro-inflammatory T-cell responses by human mesothelial cells |
| Q28541566 | Synergistic effects of ethanol and isopentenyl pyrophosphate on expansion of γδ T cells in synovial fluid from patients with arthritis |
| Q90151422 | Synthesis and Bioactivity of the Alanyl Phosphonamidate Stereoisomers Derived from a Butyrophilin Ligand |
| Q49849833 | Synthesis and Biological Evaluation of (E)-4-Hydroxy-3-Methylbut-2-enyl Phosphate (HMBP) Aryloxy Triester Phosphoramidate Prodrugs as Activators of Vγ9/Vδ2 T-Cells Immune Response. |
| Q57971830 | Synthesis and Biological Evaluation of a Phosphonate Phosphoantigen Prodrug |
| Q36301558 | Synthesis and immunological evaluation of the 4-β-glucoside of HMBPP |
| Q41593505 | Synthesis of medronic acid monoesters and their purification by high-performance countercurrent chromatography or by hydroxyapatite |
| Q26865650 | T cell recognition of non-peptidic antigens in infectious diseases |
| Q38179172 | Targeting gamma delta T cells for cancer immunotherapy: bench to bedside |
| Q27675453 | Ternary complex structures of human farnesyl pyrophosphate synthase bound with a novel inhibitor and secondary ligands provide insights into the molecular details of the enzyme’s active site closure |
| Q39079775 | The Antigen-Presenting Potential of Vγ9Vδ2 T Cells During Plasmodium falciparum Blood-Stage Infection |
| Q53838399 | The Armadillo (Dasypus novemcinctus): A Witness but Not a Functional Example for the Emergence of the Butyrophilin 3/Vγ9Vδ2 System in Placental Mammals |
| Q27682926 | The Intracellular B30.2 Domain of Butyrophilin 3A1 Binds Phosphoantigens to Mediate Activation of Human Vγ9Vδ2 T Cells |
| Q38362640 | The Jekyll and Hyde story of IL17-Producing γδT Cells |
| Q27670973 | The Molecular Basis for Modulation of Human V 9V 2 T Cell Responses by CD277/Butyrophilin-3 (BTN3A)-specific Antibodies |
| Q34741552 | The Vγ9Vδ2 T Cell Antigen Receptor and Butyrophilin-3 A1: Models of Interaction, the Possibility of Co-Evolution, and the Case of Dendritic Epidermal T Cells |
| Q50892187 | The butyrophilin 3A1 intracellular domain undergoes a conformational change involving the juxtamembrane region |
| Q52714460 | The human Vδ2+ T-cell compartment comprises distinct innate-like Vγ9+ and adaptive Vγ9- subsets |
| Q38202723 | The porcine innate immune system: an update |
| Q27030355 | The role of gamma delta T cells in haematopoietic stem cell transplantation |
| Q26995110 | The role of the γ δ T cell in allergic diseases |
| Q59806979 | Tissue Adaptations of Memory and Tissue-Resident Gamma Delta T Cells |
| Q54219852 | Towards Deciphering the Hidden Mechanisms That Contribute to the Antigenic Activation Process of Human Vγ9Vδ2 T Cells. |
| Q44732034 | Tripartite immune cell co‐operation in the Bacillus Calmette Guérin‐induced activation of γδ T cells |
| Q38819970 | Triple costimulation via CD80, 4-1BB, and CD83 ligand elicits the long-term growth of Vγ9Vδ2 T cells in low levels of IL-2. |
| Q42086300 | Tumor cell recognition by γδ T lymphocytes: T-cell receptor vs. NK-cell receptors |
| Q37706085 | Tumor-activated TCRγδ⁺ T cells from gastric cancer patients induce the antitumor immune response of TCRαβ⁺ T cells via their antigen-presenting cell-like effects. |
| Q85759121 | Tumor-killing γδ-TCRs take center stage |
| Q37990046 | Understanding the complexity of γδ T-cell subsets in mouse and human |
| Q34749889 | Vgamma2Vdelta2 T Cell Receptor recognition of prenyl pyrophosphates is dependent on all CDRs |
| Q42237075 | Vγ9 and Vδ2 T cell antigen receptor genes and butyrophilin 3 (BTN3) emerged with placental mammals and are concomitantly preserved in selected species like alpaca (Vicugna pacos). |
| Q42214986 | Vγ9Vδ2 TCR-activation by phosphorylated antigens requires butyrophilin 3 A1 (BTN3A1) and additional genes on human chromosome 6. |
| Q57492039 | Vδ2 T Cells-Two Subsets for the Price of One |
| Q55019451 | Working in "NK Mode": Natural Killer Group 2 Member D and Natural Cytotoxicity Receptors in Stress-Surveillance by γδ T Cells |
| Q55310862 | Zoledronate Triggers Vδ2 T Cells to Destroy and Kill Spheroids of Colon Carcinoma: Quantitative Image Analysis of Three-Dimensional Cultures |
| Q38986536 | Zoledronic acid causes γδ T cells to target monocytes and down-modulate inflammatory homing |
| Q40213985 | Zoledronic acid renders human M1 and M2 macrophages susceptible to Vδ2(+) γδ T cell cytotoxicity in a perforin-dependent manner. |
| Q36803818 | Zoledronic acid-induced expansion of γδ T cells from early-stage breast cancer patients: effect of IL-18 on helper NK cells |
| Q35774166 | γδ T Cell Receptors Recognize the Non-classical Major Histocompatibility Complex (MHC) Molecule T22 via Conserved Anchor Residues in a MHC Peptide-like Fashion |
| Q57425152 | γδ T cells: an immunotherapeutic approach for HIV cure strategies |
| Q37875768 | γδ T-APCs: a novel tool for immunotherapy? |
| Q38271585 | γδ T Lymphocytes as a First Line of Immune Defense: Old and New Ways of Antigen Recognition and Implications for Cancer Immunotherapy |